Risk for Myocarditis Low After BNT162b2 Booster in Israel
Physician’s Briefing Staff
TUESDAY, Sept. 6, 2022 (HealthDay News) -- The risk estimate for myocarditis in the 30 days after receipt of a COVID-19 booster dose (BNT162b2) is 1.42 per 100,000 overall,…